• S1E3: Navigating the regulatory landscape for complementary medicine: Pharmacovigilance & Adverse Reactions

  • 2021/06/13
  • 再生時間： 15 分
  • ポッドキャスト

S1E3: Navigating the regulatory landscape for complementary medicine: Pharmacovigilance & Adverse Reactions

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In our final part of this 3 part series on Regulatory Affairs in Complementary Medicine, we welcome back Sue Woldt, Senior Regulatory Affair Manager at Integria Healthcare.

    In Part 3 of this series will cover Adverse Reactions and Pharmacovigilance and your responsibilities as a practitioner. 

    Sue discusses: 

    • Definition of Pharmacovigilance (PV)
    • What is the difference between an adverse reaction and adverse event
    • Who is responsible for reporting adverse reactions and events
    • Reporting an adverse reaction
    • Wider implications- labelling and warnings

    Quick Links:

    • https://www.tga.gov.au/reporting-adverse-events 

    See omnystudio.com/listener for privacy information.
    続きを読む 一部表示

あらすじ・解説

In our final part of this 3 part series on Regulatory Affairs in Complementary Medicine, we welcome back Sue Woldt, Senior Regulatory Affair Manager at Integria Healthcare.

In Part 3 of this series will cover Adverse Reactions and Pharmacovigilance and your responsibilities as a practitioner. 

Sue discusses: 

  • Definition of Pharmacovigilance (PV)
  • What is the difference between an adverse reaction and adverse event
  • Who is responsible for reporting adverse reactions and events
  • Reporting an adverse reaction
  • Wider implications- labelling and warnings

Quick Links:

  • https://www.tga.gov.au/reporting-adverse-events 

See omnystudio.com/listener for privacy information.
続きを読む 一部表示

S1E3: Navigating the regulatory landscape for complementary medicine: Pharmacovigilance & Adverse Reactionsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。